These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23123691)
1. Tolerability profile of clonidine in the treatment of adults with Tourette syndrome. Cavanna AE; Selvini C; Termine C; Balottin U; Eddy CM Clin Neuropharmacol; 2012; 35(6):269-72. PubMed ID: 23123691 [TBL] [Abstract][Full Text] [Related]
2. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028 [TBL] [Abstract][Full Text] [Related]
3. Tolerability profile of aripiprazole in patients with Tourette syndrome. Cavanna AE; Selvini C; Termine C; Luoni C; Eddy CM; Rickards H J Psychopharmacol; 2012 Jun; 26(6):891-5. PubMed ID: 21824981 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of Tourette syndrome and its comorbidity: experience with 17 cases]. Martínez-Granero MA; Montañés Rada F; García Pérez A; de Lucas Taracena MT; Sánchez Romero S; Rafia S; Granados A; Parra Cuadrado E Neurologia; 2005 Dec; 20(10):678-85. PubMed ID: 16317589 [TBL] [Abstract][Full Text] [Related]
5. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313 [TBL] [Abstract][Full Text] [Related]
6. A review of the use of clonidine as a sleep aid in the child and adolescent population. Nguyen M; Tharani S; Rahmani M; Shapiro M Clin Pediatr (Phila); 2014 Mar; 53(3):211-6. PubMed ID: 24027233 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of Tourette's syndrome and associated disorders. Cohen DJ; Riddle MA; Leckman JF Psychiatr Clin North Am; 1992 Mar; 15(1):109-29. PubMed ID: 1549543 [TBL] [Abstract][Full Text] [Related]
8. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. Steingard R; Biederman J; Spencer T; Wilens T; Gonzalez A J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):350-3. PubMed ID: 8444764 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome. Rizzo R; Gulisano M Int Rev Neurobiol; 2013; 112():415-44. PubMed ID: 24295629 [TBL] [Abstract][Full Text] [Related]
10. Predictors of clonidine response in Tourette syndrome: implications and inferences. Lichter DG; Jackson LA J Child Neurol; 1996 Mar; 11(2):93-7. PubMed ID: 8881983 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Hedderick EF; Morris CM; Singer HS Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274 [TBL] [Abstract][Full Text] [Related]
16. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome. Mol Debes NM; Hjalgrim H; Skov L J Child Neurol; 2008 Sep; 23(9):1017-27. PubMed ID: 18827268 [TBL] [Abstract][Full Text] [Related]